Home >

Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

Planning for our first global meeting, ASCO Breakthrough: A Global Summit for Oncology Innovators, is almost complete.
Does big data have a big problem? Dr. John W. Sweetenham cautions, "There is a real danger that we legitimize flawed data sets by labelling them as 'real-world data' when they neither reflect the real world nor can we trust the data."
Patient advocate Martha E. "Meg" Gaines poses six essential questions for patient-provider teams to consider in their discussions about targeted therapies.
Dr. Chirag Shah and I were excited to participate in - and see the impact of - a campaign to raise awareness about brachytherapy as a valuable radiotherapy technique.
No matter how well you've organized your work and life, there will always be moments when you don't have enough time for everything, as Dr. Asha Karippot describes.
It was challenging to counsel a patient who responded to his cancer diagnosis by having affairs.
Dr. Zuhir Bodalal wanted to be able to offer chances to patients who would otherwise be out of options, so he needed to find a way to bridge different worlds.
Consensus among a multidisciplinary team may not be easy, but it is, ultimately, the goal. That, in and of itself, is the definition of quality care.
How does a group of talented, busy surgeons find the time to change their surgical paradigm? Dr. Nabil P. Rizk and I had an enlightening conversation about cost, value, quality of care, and process improvement.
Regardless of prognosis, we all must live with the reality that time is fleeting, and none of us have unlimited tomorrows.
Dr. David M. Waterhouse encourages you to engage with research champions at the 2019 ASCO Research Community Forum Annual Meeting.
As a physician and future pediatric oncologist, Dr. Rachel Offenbacher believes that providers have the responsibility to be vocal about the critical importance of vaccines.
"We are in a unique moment in terms of the pace of breakthroughs that are being made and the variety of places that breakthroughs are happening," writes Dr. Peter P. Yu.
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
"We believe what mattered the most about #ASCO19 is that patients were part of the discussion," write Dr. Mark A. Lewis and Dr. Chadi Nabhan.
I am excited about the entire Breakthrough program, including a session I am leading on the impact of social media and telehealth on cancer care.
Real actions that promote women and under-represented groups in medicine are doable, starting today.
"Oncologists are asked every day to peer into a crystal ball and speak sagely about how much time is left," writes Dr. Mark A. Lewis, "...but each person with cancer enters an irreproducible experiment in which they are the sole participant."

Pages


Advertisement